Live on Aug 8, 10:00 AM PDT (YouTube) 
Ideas to lND - Your Pathway to Discovery
Empowering Preclinical Innovation
Unlock the full potential of your preclinical research with Cyagen Biosciences. Our integrated solutions span from custom cell and animal model development through preclinical experiments, ensuring every phase of your project is expertly handled. Discover how we can help transform your innovative ideas into actionable outcomes and help translate your research discoveries into INDs.
Spotlight Product
Elevate your research with our Next-Generation HUGO-GTTM Humanization Models.
Explore
Innovative Solutions & Trusted Products
Special Promotions & Discounts
See All Promotions
Special Offer
50% Off iPSC Editing for New Customers
New to Cyagen? Now’s your chance to access premium iPSC gene editing services at half the cost. From knockout to overexpression models, this limited-time offer is exclusive to first-time cell line clients across North America, Europe, and Asia-Pacific. Only 100 spots available—apply early.
Explore
Free Trial
Experience Next-Level Humanized Research — Try NKG Mice for Free
Cyagen is inviting researchers in the US and EU to evaluate our NKG mice at no cost. This limited-time offer supports preclinical studies and fosters collaboration within the biomedical research community.
Explore
Special Deal
Research Now, Pay Later: Flexible Funding for Custom Animal Models
We understand that funding delays shouldn’t slow down scientific progress. Our GrantBridge provides flexible payment options to ensure that you can secure your critical research resources now while aligning payment with your funding schedule.
Explore
Your Partners in Preclinical Progress
19
Years of Genetic Innovation
7,000
Global Bioscience Partners
50,000
Mouse & Rat Models Delivered
10,925
SCI Journal Citations
250,000
SPF Animals in AAALAC-Accredited Facilities
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, January, 2025
CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis
【Cell Biology】
Nature Cancer, January, 2025
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity
【Neurobiology】
Resource Library
BLOG & INSIGHTS
More Insights
Unveiling New Frontiers in Vascular Disease Research: Novel Humanized Mouse Models for Angiogenesis
Vascular diseases, from cancer to diabetic retinopathy, pose major global health challenges. Angiopoietin-2 (ANG2), a key regulator of vascular homeostasis, is closely linked to disease progression. The clinical success of bispecific antibodies targeting ANG2 and VEGFA, such as Roche's Faricimab, highlights the urgent need for predictive animal models to advance drug discovery and development.
August 09, 2025
Schedule Meeting
UPCOMING EVENT
More
Bio Japan 2025
Meet Cyagen at Bio Japan 2025 in Yokohama—where global biotech meets preclinical innovation, and we showcase how our models accelerate drug R&D.
Schedule Meeting
WEBINAR
More
Harnessing GLP-1 and Amylin Power for Obesity Care with Reliable Preclinical In Vivo Models
GLP-1 and amylin are reshaping obesity drug development with their synergistic weight loss effects. Join our webinar to explore how Cyagen’s validated in vivo models and pharmacology services can support your preclinical research and fast-track anti-obesity drug discovery.
Schedule Meeting
FEATURED NEWS
Taconic and Cyagen Collaborate to Streamline Access to Preclinical Mouse and Rat Models
August 04, 2025
YIMA and ZIP Solutions Announce Strategic Co-Marketing Agreement for Gene Therapy
June 12, 2025
HistoWiz and Cyagen Collaborate to Streamline Histopathology for Academic and Preclinical Mouse and Rat Model Research
June 10, 2025